What'sNearbyTM

What are you looking for?

Close Search
      We apologize for the inconvenience

      The people search feature on Superpages.com is temporarily unavailable. You can still search for people on yellowpages.com since Yellow Pages and Superpages are part of one company.

      You will be automatically re-directed to People Search on yellowpages.com in .

      New York Core Neuroscience

      Add to Favorites
      Be the first to review!
      Physicians & Surgeons, Neurology, Physicians & Surgeons

      35 E 35th St Rm 206, New York, NY 10016

      845-407-8031

      CLOSED NOW: 
      Today: Closed
      CallWebsite

      REVIEWS write reviewWrite a Review

      Be the first to review!
      First-classBetter than mostAbout what I expectedNot the worst...Disappointing
      DETAILS
      General Info
      Michael Hutchinson, MD, PhD Dr. Hutchinson is a board-certified neurologist and senior faculty at the Icahn School of Medicine, Mount Sinai, Manhattan. His clinical interests include headaches, dementia, concussion, traumatic brain injury (TBI), Parkinson's Disease, multiple sclerosis, epilepsy, anxiety, and REM sleep disorders. He has an extensive scientific background and brings a science-based approach to solving clinical problems. During his residency at the University of Washington, Hutchinson used his knowledge of chaos theory to propose a new way of treating status epilepticus, the most lethal form of epilepsy. The treatment proved successful and is now standard-of-care in the US. Hutchinson later did a sabbatical at Queen Square, London, where Ian McDonald was pioneering the use of beta interferon as the first treatment for multiple sclerosis. After residency training, Hutchinson underwent a neuroimaging fellowship in Los Angeles. After arriving at NYU in 1994, Hutchinson pioneered the use of cholinesterase inhibitors as a treatment for the dementia of Parkinson's disease. At the time this was considered forbidden because it might make the patient physically worse, but Hutchinson argued that this premise was ill-conceived. Today, cholineserase inhibitors are standard-of-care in Parkinson's dementia. Hutchinson later developed a new way of treating acute relapses in multiple sclerosis, which puts the patient in charge, and has yielded impressive long-term results. During his time at NYU, Hutchinson made early contributions to functional MRI, discovering that regional brain activations during cognitive tasks are accompanied by widespread deactivations. In structural imaging, Hutchinson combined physics, neuropathology, and image processing to develop a robust MRI biomarker for Parkinson's disease. In addition to certification in neurology, Hutchinson is certified in neuroimaging (MRI and CT of the brain and spine), which combines neuroanatomy, neuropathology, and neurophysiology, fields that form the unique base of clinical neurology. Dr. Hutchinson holds a Ph.D. in molecular physics and is the inventor of spatial sensitivity encoding for MRI - sometimes referred to as parallel MRI - which is now the acknowledged standard for clinical MRI. He is currently exploring a possible extension of this to ultrafast imaging.
      Extra Phones

      Phone: 212-889-2500

      Fax: 855-850-7848

      Hours
      Regular Hours
      Mon:
      Tue:
      Wed:
      Thu:
      Fri - SunClosed
      Categories
      Physicians & Surgeons, Neurology, Physicians & Surgeons
      Services/Products
      Back Pain Headache Multiple Sclerosis Numbness Parkinson's Disease Seizures Stroke Tremor
      Payment Options
      Other Link

      website

      Provided by
      Data provided by one or more of the following: Thryv, Data Axle, Yext.